These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 35120786)

  • 41. A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis.
    Pasero D; Sanna S; Liperi C; Piredda D; Branca GP; Casadio L; Simeo R; Buselli A; Rizzo D; Bussu F; Rubino S; Terragni P
    Infection; 2021 Oct; 49(5):1055-1060. PubMed ID: 33331988
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pathogenesis of COVID-19-associated mucormycosis (CAM) in India: probing the triggering factors.
    Arakeri G; Patil S; Rao Us V; Amaral Mendes R; Oeppen RS; Brennan PA
    Br J Oral Maxillofac Surg; 2022 May; 60(4):e533-e534. PubMed ID: 35351328
    [No Abstract]   [Full Text] [Related]  

  • 43. Mucormycosis with Severe Acute Respiratory Syndrome Coronavirus-2 Patients on Hemodialysis: A Case Series with Review of Literature.
    Dabas A; Swarnim S; Sagar T; Mantan M
    Saudi J Kidney Dis Transpl; 2021; 32(4):1152-1157. PubMed ID: 35229816
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mucormycosis in head and neck area - the emerging health problem in COVID-19 pandemic. The perspective of a dental practitioner.
    Pasternak M; Olszanecki R
    Folia Med Cracov; 2021; 61(2):117-127. PubMed ID: 34510169
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World.
    Muthu V; Rudramurthy SM; Chakrabarti A; Agarwal R
    Mycopathologia; 2021 Dec; 186(6):739-754. PubMed ID: 34414555
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk factors associated with the mucormycosis epidemic during the COVID-19 pandemic.
    Bhanuprasad K; Manesh A; Devasagayam E; Varghese L; Cherian LM; Kurien R; Karthik R; Deodhar D; Vanjare H; Peter J; Michael JS; Thomas M; Samuel P; Varghese GM
    Int J Infect Dis; 2021 Oct; 111():267-270. PubMed ID: 34450284
    [TBL] [Abstract][Full Text] [Related]  

  • 47. COVID-19 associated mucormycosis - An emerging threat.
    Chao CM; Lai CC; Yu WL
    J Microbiol Immunol Infect; 2022 Apr; 55(2):183-190. PubMed ID: 35074291
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Covid-19 and mucormycosis (Black Fungus): An epidemic within the pandemic.
    Gambhir RS; Aggarwal A; Bhardwaj A; Kaur A; Sohi RK; Mehta S
    Rocz Panstw Zakl Hig; 2021; 72(3):239-244. PubMed ID: 34553877
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cutaneous mucormycosis: an unusual cause of decompensation in a patient with ethanol-related cirrhosis with COVID-19 exposure.
    Menezes S; Kumar JS; Rudra OS; Nagral A
    BMJ Case Rep; 2022 Feb; 15(2):. PubMed ID: 35140094
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pediatric Mucormycosis and COVID-19.
    Yadav S
    J Contemp Dent Pract; 2021 Aug; 22(8):855. PubMed ID: 34753834
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach.
    Azhar A; Khan WH; Khan PA; Alhosaini K; Owais M; Ahmad A
    J Infect Public Health; 2022 Apr; 15(4):466-479. PubMed ID: 35216920
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients.
    Bansal SB; Rana A; Babras M; Yadav D; Jha P; Jain M; Sethi SK
    Transpl Infect Dis; 2022 Apr; 24(2):e13777. PubMed ID: 34932870
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mucormycosis in COVID-19 patients.
    Sundaram N; Bhende T; Yashwant R; Jadhav S; Jain A
    Indian J Ophthalmol; 2021 Dec; 69(12):3728-3733. PubMed ID: 34827032
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India.
    Patel A; Agarwal R; Rudramurthy SM; Shevkani M; Xess I; Sharma R; Savio J; Sethuraman N; Madan S; Shastri P; Thangaraju D; Marak R; Tadepalli K; Savaj P; Sunavala A; Gupta N; Singhal T; Muthu V; Chakrabarti A;
    Emerg Infect Dis; 2021 Sep; 27(9):2349-2359. PubMed ID: 34087089
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mixed mold infection with
    Bellanger AP; Navellou JC; Lepiller Q; Brion A; Brunel AS; Millon L; Berceanu A
    Infect Dis Now; 2021 Oct; 51(7):633-635. PubMed ID: 33527098
    [No Abstract]   [Full Text] [Related]  

  • 56. Covid-19 associated Mucormycosis: A case report.
    Shrestha O; Sharma Baral R
    J Nepal Health Res Counc; 2021 Sep; 19(2):414-416. PubMed ID: 34601541
    [TBL] [Abstract][Full Text] [Related]  

  • 57. How Does Mucorales Benefit from the Dysregulated Iron Homeostasis During SARS-CoV-2 Infection?
    Lugito NPH; Cucunawangsih C
    Mycopathologia; 2021 Dec; 186(6):877-882. PubMed ID: 34623597
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rhizopus homothallicus: An emerging pathogen in era of COVID-19 associated mucormycosis.
    Kaur H; Kanaujia R; Rudramurthy SM
    Indian J Med Microbiol; 2021; 39(4):473-474. PubMed ID: 34266698
    [No Abstract]   [Full Text] [Related]  

  • 59. Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review.
    Bhattacharyya A; Sarma P; Sharma DJ; Das KK; Kaur H; Prajapat M; Kumar S; Bansal S; Prakash A; Avti P; Thota P; Reddy DH; Gautam BS; Medhi B
    Indian J Pharmacol; 2021; 53(4):317-327. PubMed ID: 34414911
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.